CQC Case Study: Ampersand’s MyIBD Care – Home Monitoring for Patients with IBD
Posted on 05 Aug 2019
The CQC is the independent regulator of health and social care in England. Their purpose is to make sure people are provided with safe, effective, and high-quality care. They have recently published a series of case studies about driving improvement through technology and MyIBD Care has been selected as a new Telemonitoring technology.
{Times Magazine distribution} Future of Healthcare Report – August 2020
12 Aug 2020
In this report, Raconteur highlights the explosion of symptom tracker app such as Ampersand's My IBD Care platform.
Press Release: Calpro X Ampersand Health
21 Oct 2021
Ampersand Health and Calpro AS, a Svar Life Science company, have announced a new partnership integrating the CalproSmart™ Self-Test into Ampersand’s My...
My IBD Care achieves a top score of 85% on the Orcha App Store
09 Jul 2019
My IBD Care, an app for patients with Inflammatory Bowel Disease, has entered the Orcha listings as the highest rated app in its segment.
Ampersand – part of Global Digital Health 100
31 Aug 2018
